{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:42:13Z","timestamp":1791049333165,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1124\/jpet.103.055855","type":"journal-article","created":{"date-parts":[[2004,3,26]],"date-time":"2004-03-26T18:07:46Z","timestamp":1080324466000},"page":"275-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Novel Dual Action AT1 and ETA Receptor Antagonists Reduce Blood Pressure in Experimental Hypertension"],"prefix":"10.1016","volume":"309","author":[{"given":"Mark C.","family":"Kowala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natesan","family":"Murugesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Tellew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossain","family":"Monshizadegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengxiang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridgette","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Fadnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose Ann","family":"Baska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pam","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Giancarli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jergen","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balkrushna","family":"Panchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Trippodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Barrish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Macor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.103.055855_bib1","doi-asserted-by":"crossref","unstructured":"Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol Chemother 14: 48-58.","DOI":"10.1111\/j.1476-5381.1959.tb00928.x"},{"key":"10.1124\/jpet.103.055855_bib2","doi-asserted-by":"crossref","unstructured":"Bird JE, Moreland S, Waldron TL, and Powell JR (1995) Antihypertensive effects of a novel endothelin-A receptor antagonist in rats. Hypertension 25: 1191-1195.","DOI":"10.1161\/01.HYP.25.6.1191"},{"key":"10.1124\/jpet.103.055855_bib3","doi-asserted-by":"crossref","unstructured":"Cazoubon C, Gougat J, Bousquet F, Guiraudou P, Gayraud R, Lacour C, Roccon A, Galindo G, Barthelemy G, Gautret B, et al. (1993) Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist. J Pharmacol Exp Ther 265: 826-834.","DOI":"10.1016\/S0022-3565(25)38210-8"},{"key":"10.1124\/jpet.103.055855_bib4","doi-asserted-by":"crossref","unstructured":"Dickinson KEJ, Cohen RB, Skwish S, Delaney CL, Serafino RP, Poss MA, Gu Z, Ryono DE, Moreland S, and Powell JR (1994) BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated response: comparison with losartan and EXP3174. Br J Pharmacol 113: 179-189.","DOI":"10.1111\/j.1476-5381.1994.tb16191.x"},{"key":"10.1124\/jpet.103.055855_bib5","doi-asserted-by":"crossref","unstructured":"DiNicolantonio R and Doyle AE (1985) Comparison of the actions of the angiotensin-converting enzyme (ACE) inhibitors enalarpril and S-9490-3 in sodium-deplete and sodium-replete spontaneously hypertensive rats. J Cardiovasc Pharmacol 7: 937-942.","DOI":"10.1097\/00005344-198509000-00019"},{"key":"10.1124\/jpet.103.055855_bib6","doi-asserted-by":"crossref","unstructured":"d\u2019Uscio LV, Shaw S, Barton M, and Luscher T (1998) Losartan but not verapamil inhibits angiotensin II-induced tissue endothelin-1 increase. Hypertension 31: 1305-1310.","DOI":"10.1161\/01.HYP.31.6.1305"},{"key":"10.1124\/jpet.103.055855_bib7","doi-asserted-by":"crossref","unstructured":"Emori T, Hirata Y, Ohta K, Kanno K, Eguchi S, Imai T, Shichiri M, and Marumo F (1991) Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension 18: 165-170.","DOI":"10.1161\/01.HYP.18.2.165"},{"key":"10.1124\/jpet.103.055855_bib8","doi-asserted-by":"crossref","unstructured":"Fujita K, Matsumura Y, Kita S, Miyazaki Y, Hisaki K, Takaoka M, and Morimoto S (1995) Role of endothelin-1 and the ETA receptor in the maintainence of deoxycorticosterone acetate-salt-induced hypertension. Br J Pharmacol 114: 925-930.","DOI":"10.1111\/j.1476-5381.1995.tb13292.x"},{"key":"10.1124\/jpet.103.055855_bib9","doi-asserted-by":"crossref","unstructured":"Gardiner SM, March JE, Kemp PA, Mullins JJ, and Bennett T (1995) Hemodynamic effects of losartan and the endothelin antagonists, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats. Br J Pharmacol 116: 2237-2244.","DOI":"10.1111\/j.1476-5381.1995.tb15059.x"},{"key":"10.1124\/jpet.103.055855_bib10","doi-asserted-by":"crossref","unstructured":"Horning B, Kohler C, Schlink D, Tatge H, and Drexler H (2003) AT1-receptor antagonism improves endothelial function in coronary artery disease in a brady-kinin\/B2-receptor-dependent mechanism. Hypertension 41: 1092-1095.","DOI":"10.1161\/01.HYP.0000064942.77814.26"},{"key":"10.1124\/jpet.103.055855_bib11","doi-asserted-by":"crossref","unstructured":"Ikeda T, Ohta H, Okada M, Kawai N, Nakao R, Siegl PKS, Koybayashi T, Miyauchi T, and Nishikibe M (2000) Antihypertensive effects of a mixed endothelin-A- and -B-receptor antagonists, J-104132, were augmented in the presence of a AT1-receptor antagonist, MK-954. J Cardiovasc Pharmacol 36: S337-S341.","DOI":"10.1097\/00005344-200036001-00098"},{"key":"10.1124\/jpet.103.055855_bib12","doi-asserted-by":"crossref","unstructured":"Imai T, Hirata Y, Emori T, Yanagisawa M, Masaki T, and Marumo F (1992) Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension 19: 753-757.","DOI":"10.1161\/01.HYP.19.6.753"},{"key":"10.1124\/jpet.103.055855_bib13","doi-asserted-by":"crossref","unstructured":"Kawaguchi H, Sawa H, and Yasuda H (1990) Endothelin stimulates angiotensin I to angiotensin II conversion in cultured pulmonary artery endothelial cells. J Mol Cell Cardiol 22: 839-842.","DOI":"10.1016\/0022-2828(90)90115-I"},{"key":"10.1124\/jpet.103.055855_bib14","doi-asserted-by":"crossref","unstructured":"Kitami Y, Hiwada K, and Kokubu T (1989) Kidney renin gene expression in spontaneously hypertensive rats. J Hypertens 7: 727-731.","DOI":"10.1097\/00004872-198909000-00006"},{"key":"10.1124\/jpet.103.055855_bib15","doi-asserted-by":"crossref","unstructured":"Krum H, Viskoper RJ, Lacourciere Y, Budde M, and Charlton V (1998) The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. N Engl J Med 338: 784-790.","DOI":"10.1056\/NEJM199803193381202"},{"key":"10.1124\/jpet.103.055855_bib16","doi-asserted-by":"crossref","unstructured":"Lacour C, Canals F, Galindo G, Cazaubon C, Segondy D, and Nisato D (1994) Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rats models. Eur J Pharmacol 264: 307-316.","DOI":"10.1016\/0014-2999(94)00484-6"},{"key":"10.1124\/jpet.103.055855_bib17","doi-asserted-by":"crossref","unstructured":"Lee JY, Warner RB, Brune ME, Adler AL, Winn M, De B, Zydowsky TM, Opgenorth TJ, Kerkman DJ, and DeBernardis JF (1994) Cardiovascular effects of orally administered ABBOTT-81988, an angiotensin II antagonist, in conscious spontaneously hypertensive rats. Am J Hypertens 7: 975-983.","DOI":"10.1093\/ajh\/7.11.975"},{"key":"10.1124\/jpet.103.055855_bib18","unstructured":"Lee RJ and Brunner HR (1993) Clinical experience with angiotensin II receptor antagonists. J Hum Hypertens 7: S33-S36."},{"key":"10.1124\/jpet.103.055855_bib19","doi-asserted-by":"crossref","unstructured":"Murugesan N, Gu Z, Spergel S, Young M, Chen P, Liu ECK, Zhang R, Bird E, Waldron T, Marino A, et al. (2003) Biphenylsulfonamide endothelin receptor antagonists. 4. Discovery of BMS-207940, a highly potent and orally active ETA selective antagonist. J Med Chem 46: 125-137.","DOI":"10.1021\/jm020289q"},{"key":"10.1124\/jpet.103.055855_bib20","doi-asserted-by":"crossref","unstructured":"Murugesan N, Gu Z, Stein PD, Spergel S, Mathur A, Leith L, Liu ECK, Zhang R, Bird E, Waldron T, et al. (2000) Biphenylsulfonamide endothelin receptor antagonists. 2: Discovery of 4\u2032-oxazolyl biphenylsulfonamides as a new class of potent, highly selective ETA antagonists. J Med Chem 43: 3111-3117.","DOI":"10.1021\/jm000105c"},{"key":"10.1124\/jpet.103.055855_bib21","doi-asserted-by":"crossref","unstructured":"Murugesan N, Tellew JE, Gu Z, Kunst BL, Fadnis L, Cornelius LA, Baska RAF, Yang Y, Beyer SM, Monshizadegan H, et al. (2002) Discovery of N-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonists. J Med Chem 45: 3829-3835.","DOI":"10.1021\/jm020138n"},{"key":"10.1124\/jpet.103.055855_bib22","doi-asserted-by":"crossref","unstructured":"Pollock DM, Derebail VK, Yamamoto T, and Pollock JS (2000) Combined effects of AT(1) and ET(A) receptor antagonists, candesartan and A-127722 in DOCA-salt hypertensive rats. Gen Pharmacol 34: 337-342.","DOI":"10.1016\/S0306-3623(00)00079-3"},{"key":"10.1124\/jpet.103.055855_bib23","doi-asserted-by":"crossref","unstructured":"Robertson MJ, Barnes JC, Drew GM, Clark KL, Marshall FH, Michael A, Middlemiss D, Ross BC, Scopes D, and Dowle MD (1992) Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist. Br J Pharmacol 107: 1173-1180.","DOI":"10.1111\/j.1476-5381.1992.tb13425.x"},{"key":"10.1124\/jpet.103.055855_bib24","doi-asserted-by":"crossref","unstructured":"Schiffrin EL, Lariviere R, Li JS, and Sventek P (1996) Enhanced expression of endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure. J Vasc Res 33: 235-248.","DOI":"10.1159\/000159151"},{"key":"10.1124\/jpet.103.055855_bib25","doi-asserted-by":"crossref","unstructured":"Schiffrin EL, Turgeon A, and Deng LY (1997) Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats. Br J Pharmacol 121: 935-940.","DOI":"10.1038\/sj.bjp.0701224"},{"key":"10.1124\/jpet.103.055855_bib26","doi-asserted-by":"crossref","unstructured":"Seymour AA, Norman JA, Asaad MM, Fennell SA, Little DK, Kratunis VJ, and Rogers WL (1991) Anti-hypertensive and renal activity of SQ 28,603, an inhibitor of neutral endopeptidase. J Cardiovasc Pharmacol 17: 296-304.","DOI":"10.1097\/00005344-199102000-00016"},{"key":"10.1124\/jpet.103.055855_bib27","doi-asserted-by":"crossref","unstructured":"van den Meiracker AH, Admiraal PJ, Janssen JA, Kroodsma JM, de Ronde WA, Boomsma F, Sissmann J, Blankestijn PJ, Mulder PG, and Man In\u2019t Veld AJ (1995) Hemodynamic and biochemical effects of the AT1 receptor antagonist irbesartan in hypertension. Hypertension 25: 22-29.","DOI":"10.1161\/01.HYP.25.1.22"},{"key":"10.1124\/jpet.103.055855_bib28","doi-asserted-by":"crossref","unstructured":"Wada T, Kanagawa R, Ishimura Y, and Nishikawa K (1995) Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats. J Hypertens 13: 113-122.","DOI":"10.1097\/00004872-199501000-00017"},{"key":"10.1124\/jpet.103.055855_bib29","doi-asserted-by":"crossref","unstructured":"Walsh TF, Fitch KJ, Williams DL Jr, Murphy KL, Nolan NA, Pettibone DJ, Chang RSL, O\u2019Malley SS, Clineschmidt BV, Veber DF, et al. (1995) Potent dual antagonists of endothelin and angiotensin II receptors derived from \u03b1-phenoxyphenylacetic acids (part III). Biorg Med Chem Letters 5: 1155-1158.","DOI":"10.1016\/0960-894X(95)00186-W"},{"key":"10.1124\/jpet.103.055855_bib30","doi-asserted-by":"crossref","unstructured":"Webb ML, Dickinson KEJ, Delaney CL, Liu EC-K, Serafino R, Cohen RB, Monshizadegan H, and Moreland S (1992) The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aorta. Biochem Biophys Res Commun 185: 887-892.","DOI":"10.1016\/0006-291X(92)91710-8"},{"key":"10.1124\/jpet.103.055855_bib31","doi-asserted-by":"crossref","unstructured":"Webb RL, Navarrete AE, Davis S, and de Gasparo M (1998) Synergistic effects of combined enzyme inhibition and angiotensin II antagonism on blood pressure in conscious telemetered spontaneously hypertensive rats. J Hypertens 16: 843-852.","DOI":"10.1097\/00004872-199816060-00016"},{"key":"10.1124\/jpet.103.055855_bib32","doi-asserted-by":"crossref","unstructured":"Wenzel RR, Ruthermann J, Bruck H, Schafers RF, Michel MC, and Philipp TH (2001) Endothelin-A receptor antagonist inhibits angiotensin II and noradrenalin in man. Br J Clin Pharmacol 52: 151-157.","DOI":"10.1046\/j.0306-5251.2001.01422.x"},{"key":"10.1124\/jpet.103.055855_bib33","doi-asserted-by":"crossref","unstructured":"Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui, Yazaki Y, Goto K, and Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (Lond) 332: 411-415.","DOI":"10.1038\/332411a0"},{"key":"10.1124\/jpet.103.055855_bib34","doi-asserted-by":"crossref","unstructured":"Yoshida K, Yasujima M, Kohzuki M, Kanazawa M, Yoshinaga K, and Abe K (1992) Endothelin-1 augments pressor response to angiotensin II infusion in rats. Hypertension 20: 292-297.","DOI":"10.1161\/01.HYP.20.3.292"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524312753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524312753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.103.055855","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:50:10Z","timestamp":1739998210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524312753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0022356524312753"],"URL":"https:\/\/doi.org\/10.1124\/jpet.103.055855","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Dual Action AT1 and ETA Receptor Antagonists Reduce Blood Pressure in Experimental Hypertension","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.103.055855","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}